Importantly, HMGA2 knockdown did not reduce total cellular TRF2 protein levels in cancer cells indicating that this telomere dysfunction signaling phenotype was specific to the HMGA2 knockdown and associated with reduced telomeric localization of TRF2. The gene discussed is TERF2; the disease is cancer.